Personalized Medicine: A Reality Within this Decade
- 26 January 2008
- journal article
- review article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 1 (1) , 11-16
Abstract
Personalized medicine is defined as individualized treatment based on the individual’s genetic variants. Such treatment has the potential to enable pharmacogenetics, such as the prevention of 100,000 deaths per year in the USA because of adverse drug reactions or specify treatment in heart failure such at the beta 1 adrenergic receptor polymorphisms. It is claimed that coronary artery disease (CAD) is at least 50% because of genetic predisposition. Identification of the genes predisposing to CAD would greatly facilitate prevention, early treatment, and more specific therapies. The arrival of the multimillion single nucleotide polymorphism (SNP) array provides the high throughput genotyping required to perform genome-wide Association (GWA) studies. These studies require markers (SNPs) at intervals of 6,000 bp and sample size of several thousands. Platforms are available to genotype and process millions of genotypes per day. The GWA performed by the Ottawa Heart Genomic Study identified the first deoxyribonucleic acid region (9p21) predisposing to CAD after replication in six independent populations totaling 23,000. This was subsequently confirmed in several independent studies totally more than 45,000 individuals. The region confers a risk for CAD independent of known risk factors. 9p21 occurs in heterozygous form in 40 to 50% of Caucasians with increased risk of 15 to 20% and in homozygous form in 25% of Caucasians with increased risk of 40%. Identification of the genes predisposing to CAD is a prerequisite for personalized care of these patients. It is anticipated that most of the genes predisposing to CAD will be identified in the next 5 to 8 years. The 9p21, in addition to conferring increased risk, provides the bonus of being independent of known risk factors. Thus, 9p21 is likely to provide the impetus and nidus for a major research effort over the next few years. It has the potential to not only provide for early genetic screening but also as a target for novel therapy.Keywords
This publication has 31 references indexed in Scilit:
- Incidence of Coronary Artery Disease in Siblings of Patients With Premature Coronary Artery Disease: 10 Years of Follow-upThe American Journal of Cardiology, 2007
- The Diploid Genome Sequence of an Individual HumanPLOS Biology, 2007
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- A Common Allele on Chromosome 9 Associated with Coronary Heart DiseaseScience, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Genetic Analysis of 103 Candidate Genes for Coronary Artery Disease and Associated Phenotypes in a Founder Population Reveals a New Association between Endothelin-1 and High-Density Lipoprotein CholesterolThe American Journal of Human Genetics, 2007
- A genome-wide association study identifies novel risk loci for type 2 diabetesNature, 2007
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- The International HapMap ProjectNature, 2003
- Familial Patterns in Ischaemic Heart DiseaseJournal of Epidemiology and Community Health, 1964